|
|
|
|
|
|
|
|
|
|
|
|
|
29.04.26 - 22:09
|
Teladoc Health Reports First Quarter 2026 Results (GlobeNewswire EN)
|
|
|
NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 (“First Quarter 2026”). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2025 (“First Quarter 2025”)....
|
|
|
|
|
|
|
|
|
15.04.26 - 22:06
|
Teladoc Health to Announce First Quarter 2026 Financial Results (GlobeNewswire EN)
|
|
|
NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release first quarter 2026 results on Wednesday, April 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.03.26 - 22:33
|
Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors (GlobeNewswire EN)
|
|
|
NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Susan Salka to its board of directors, effective immediately. Ms. Salka is the former president and CEO of AMN Healthcare Services, a provider of healthcare workforce technology solutions and staffing services to healthcare facilities across the US. She joins following the retirements of Eric Evans and Thomas McKinley and the appointment of Michael Smith. She will serve on the board's audit and compensation committees....
|
|
|
|
|
26.03.26 - 15:02
|
Teledoc (TDOC) Gets a $7 Price Target From Barclays: Can It Double From Recent Lows? (24/7 Wall St.)
|
|
|
Teladoc Health (NYSE:TDOC) has staged a notable recovery off its lows, but the stock remains under significant pressure from its longer-term trajectory. Shares are up 1.37% over the past week and have gained 3.83% over the past month, yet they remain down 21.21% year-to-date and nearly 36% over the past year. The stock sits well ... Teledoc (TDOC) Gets a $7 Price Target From Barclays: Can It Double From Recent Lows?
The post Teledoc (TDOC) Gets a $7 Price Target From Barclays: Can It Double From Recent Lows? appeared first on 24/7 Wall St.....
|
|